AAAAAA

   
Results: 1-25 | 26-43 |
Results: 26-43/43

Authors: Abdel-Rahman, SM Nahata, MC
Citation: Sm. Abdel-rahman et Mc. Nahata, Stability of fumagillin in an extemporaneously prepared ophthalmic solution, AM J HEAL S, 56(6), 1999, pp. 547-550

Authors: Nahata, MC Morosco, RS Hipple, TF
Citation: Mc. Nahata et al., Stability of lamotrigine in two extemporaneously prepared oral suspensionsat 4 and 25 degrees C, AM J HEAL S, 56(3), 1999, pp. 240-242

Authors: Abdel-Rahman, SM Nahata, MC
Citation: Sm. Abdel-rahman et Mc. Nahata, Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 degrees C, AM J HEAL S, 56(3), 1999, pp. 243-245

Authors: Wandstrat, TL Kaplan-Machlis, B Temple, ME Nahata, MC
Citation: Tl. Wandstrat et al., Tetravalent rotavirus vaccine, ANN PHARMAC, 33(7-8), 1999, pp. 833-839

Authors: Temple, ME Nahata, MC
Citation: Me. Temple et Mc. Nahata, Interaction between ciprofloxacin and rifampin, ANN PHARMAC, 33(7-8), 1999, pp. 868-870

Authors: Carlisle, SS Nahata, MC
Citation: Ss. Carlisle et Mc. Nahata, Chlamydia pneumoniae and coronary heart disease, ANN PHARMAC, 33(5), 1999, pp. 615-622

Authors: Pai, VB Nahata, MC
Citation: Vb. Pai et Mc. Nahata, Nelfinavir mesylate: A protease inhibitor, ANN PHARMAC, 33(3), 1999, pp. 325-339

Authors: Nahata, MC
Citation: Mc. Nahata, Pediatric drug formulations: Challenges and potential solutions, ANN PHARMAC, 33(2), 1999, pp. 247-249

Authors: Temple, ME Nahata, MC
Citation: Me. Temple et Mc. Nahata, Rifapentine: Its role in the treatment of tuberculosis, ANN PHARMAC, 33(11), 1999, pp. 1203-1210

Authors: Alghasham, AA Nahata, MC
Citation: Aa. Alghasham et Mc. Nahata, Trovafloxacin: A new fluoroquinolone, ANN PHARMAC, 33(1), 1999, pp. 48-60

Authors: Tallian, KB Nahata, MC Turman, MA Mahan, JD Hayes, JR Mentser, MI
Citation: Kb. Tallian et al., Efficacy of amlodipine in pediatric patients with hypertension, PED NEPHROL, 13(4), 1999, pp. 304-310

Authors: Nahata, MC
Citation: Mc. Nahata, Development of two stable oral suspensions for gabapentin, PED NEUROL, 20(3), 1999, pp. 195-197

Authors: Nahata, MC Tallian, KB Force, RW
Citation: Mc. Nahata et al., Pharmacokinetics of fluconazole in young infants, EUR J DRUG, 24(2), 1999, pp. 155-157

Authors: Robinson, RF Nahata, MC
Citation: Rf. Robinson et Mc. Nahata, A comparative review of conventional and lipid formulations of amphotericin B, J CLIN PH T, 24(4), 1999, pp. 249-257

Authors: Nahata, MC Vashi, VI Swanson, RN Messig, MA Chung, M
Citation: Mc. Nahata et al., Pharmacokinetics of ampicillin and sulbactam in pediatric patients, ANTIM AG CH, 43(5), 1999, pp. 1225-1229

Authors: Nahata, MC
Citation: Mc. Nahata, Lack of pediatric drug formulations, PEDIATRICS, 104(3), 1999, pp. 607-609

Authors: Nahata, MC Morosco, RS Hipple, TF
Citation: Mc. Nahata et al., Stability of granisetron hydrochloride in two oral suspensions, AM J HEAL S, 55(23), 1998, pp. 2511-2513

Authors: Cassady, JM DiPiro, JT Foster, TS Hak, LJ Hill, WT Kirshstein, R Lindley, CM Nahata, MC Robinson, JR Stinnett, AA Murphy, JE Manasse, HR Witmer, DR
Citation: Jm. Cassady et al., Report of the ASHP Task Force on Science, AM J HEAL S, 55(23), 1998, pp. 2519-2524
Risultati: 1-25 | 26-43 |